ADA-话题@MedSci

#ADA#

386篇内容 | 4030人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264542, encodeId=f6d11264542a1, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015: 糖尿病依然是世界主要疾病，呼唤突破性药物/outcome证据, objectType=article, longId=51802, objectId=3f1c51802b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f1c51802b0, replyNumber=0, likeNumber=27, createdTime=2015-06-10, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f1c51802b0, moduleTitle=ADA 2015: 糖尿病依然是世界主要疾病，呼唤突破性药物/outcome证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f1c51802b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264541, encodeId=4420126454127, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：SAVOR-TIMI53试验：沙格列汀未增加2型糖尿病患者癌症风险, objectType=article, longId=51773, objectId=239151e7379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=239151e7379, replyNumber=0, likeNumber=0, createdTime=2015-06-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=239151e7379, moduleTitle=ADA 2015：SAVOR-TIMI53试验：沙格列汀未增加2型糖尿病患者癌症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=239151e7379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264540, encodeId=c43212645400e, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：阿格列汀未增加ACS患者心血管事件(EXAMINE试验), objectType=article, longId=51772, objectId=dc6351e721e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc6351e721e, replyNumber=0, likeNumber=38, createdTime=2015-06-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc6351e721e, moduleTitle=ADA 2015：阿格列汀未增加ACS患者心血管事件(EXAMINE试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc6351e721e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264539, encodeId=24c712645396c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：ELIXA试验将公布结果, objectType=article, longId=51771, objectId=4b8651e71f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b8651e71f1, replyNumber=0, likeNumber=30, createdTime=2015-06-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b8651e71f1, moduleTitle=ADA 2015：ELIXA试验将公布结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b8651e71f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264538, encodeId=975612645389e, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Circulation：Brugada综合征患者心脏电生理基质在ECG的表型和电图异常, objectType=article, longId=51770, objectId=b6c151e70a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6c151e70a1, replyNumber=0, likeNumber=26, createdTime=2015-06-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c151e70a1, moduleTitle=Circulation：Brugada综合征患者心脏电生理基质在ECG的表型和电图异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6c151e70a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264537, encodeId=71a7126453e05, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：TECOS试验将公布结果, objectType=article, longId=51769, objectId=b77251e69b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b77251e69b8, replyNumber=0, likeNumber=33, createdTime=2015-06-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b77251e69b8, moduleTitle=ADA 2015：TECOS试验将公布结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b77251e69b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264536, encodeId=fb57126453635, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：糖尿病专家观点直击, objectType=article, longId=51765, objectId=952551e6564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=952551e6564, replyNumber=0, likeNumber=43, createdTime=2015-06-08, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=952551e6564, moduleTitle=ADA 2015：糖尿病专家观点直击, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=952551e6564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264535, encodeId=035e12645359f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2015：糖尿病领域亮点抢先看, objectType=article, longId=51702, objectId=b40d51e026b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40d51e026b, replyNumber=0, likeNumber=47, createdTime=2015-06-06, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40d51e026b, moduleTitle=ADA 2015：糖尿病领域亮点抢先看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40d51e026b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264534, encodeId=7c8d1264534a6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2015 ADA年会：β细胞替换疗法的未来, objectType=article, longId=51547, objectId=fd825154e1d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd825154e1d, replyNumber=0, likeNumber=42, createdTime=2015-06-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd825154e1d, moduleTitle=2015 ADA年会：β细胞替换疗法的未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd825154e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264533, encodeId=381912645337a, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2015 ADA精彩专题内容抢先看, objectType=article, longId=51517, objectId=de365151e82, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de365151e82, replyNumber=0, likeNumber=31, createdTime=2015-06-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de365151e82, moduleTitle=2015 ADA精彩专题内容抢先看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de365151e82)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264532, encodeId=1d1e12645324e, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA：2015年糖尿病诊疗标准精简版, objectType=article, longId=50194, objectId=11a65019432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a65019432, replyNumber=0, likeNumber=34, createdTime=2015-05-06, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a65019432, moduleTitle=ADA：2015年糖尿病诊疗标准精简版, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a65019432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264531, encodeId=8834126453125, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Headache：孕期偏头痛，警惕代谢疾病, objectType=article, longId=49886, objectId=db5749886cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5749886cb, replyNumber=0, likeNumber=0, createdTime=2015-04-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5749886cb, moduleTitle=Headache：孕期偏头痛，警惕代谢疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db5749886cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264530, encodeId=602a12645308a, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JADA：健康的微笑离不开健康的牙龈, objectType=article, longId=49880, objectId=1c9649880e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c9649880e0, replyNumber=0, likeNumber=51, createdTime=2015-04-27, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c9649880e0, moduleTitle=JADA：健康的微笑离不开健康的牙龈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c9649880e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264529, encodeId=0278126452991, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=专家解读2015ADA/EASD高血糖管理立场声明, objectType=article, longId=48398, objectId=ad9b48398ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9b48398ed, replyNumber=0, likeNumber=0, createdTime=2015-03-21, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9b48398ed, moduleTitle=专家解读2015ADA/EASD高血糖管理立场声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9b48398ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264528, encodeId=da951264528bc, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Headache：美国头痛学会AHS 急性偏头痛的药物治疗, objectType=article, longId=46749, objectId=f79046e493c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f79046e493c, replyNumber=0, likeNumber=30, createdTime=2015-02-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f79046e493c, moduleTitle=Headache：美国头痛学会AHS 急性偏头痛的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f79046e493c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264527, encodeId=9527126452e3c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA和EASD联合发布：全新2型糖尿病管理指南, objectType=article, longId=46597, objectId=56ac4659ead, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56ac4659ead, replyNumber=0, likeNumber=39, createdTime=2015-02-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56ac4659ead, moduleTitle=ADA和EASD联合发布：全新2型糖尿病管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56ac4659ead)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264526, encodeId=eee9126452692, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, objectType=article, longId=45399, objectId=22784539980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22784539980, replyNumber=0, likeNumber=28, createdTime=2015-01-15, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22784539980, moduleTitle=免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22784539980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264525, encodeId=3afe126452531, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=拜耳造影剂Gadavist新适应症获FDA批准，用于两周岁以下患儿, objectType=article, longId=45126, objectId=e0a5451262d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0a5451262d, replyNumber=0, likeNumber=37, createdTime=2015-01-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0a5451262d, moduleTitle=拜耳造影剂Gadavist新适应症获FDA批准，用于两周岁以下患儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0a5451262d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264524, encodeId=84d0126452445, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=逆袭！赛诺菲多发性硬化症新药Lemtrada获FDA批准上市, objectType=article, longId=42830, objectId=d5b4428304b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5b4428304b, replyNumber=0, likeNumber=24, createdTime=2014-11-21, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5b4428304b, moduleTitle=逆袭！赛诺菲多发性硬化症新药Lemtrada获FDA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5b4428304b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：良好血糖控制有助于降低心血管事件（CREDIT研究）, objectType=article, longId=37487, objectId=c5153e487c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5153e487c1, replyNumber=0, likeNumber=34, createdTime=2014-07-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5153e487c1, moduleTitle=ADA 2014：良好血糖控制有助于降低心血管事件（CREDIT研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5153e487c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015: 糖尿病依然是世界主要疾病，呼唤突破性药物/outcome证据

2015-06-10

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：SAVOR-TIMI53试验：沙格列汀未增加2型糖尿病患者癌症风险

2015-06-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：阿格列汀未增加ACS患者心血管事件(EXAMINE试验)

2015-06-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：ELIXA试验将公布结果

2015-06-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Circulation：Brugada综合征患者心脏电生理基质在ECG的表型和电图异常

2015-06-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：TECOS试验将公布结果

2015-06-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：糖尿病专家观点直击

2015-06-08

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2015：糖尿病领域亮点抢先看

2015-06-06

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2015 ADA年会：β细胞替换疗法的未来

2015-06-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2015 ADA精彩专题内容抢先看

2015-06-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA：2015年糖尿病诊疗标准精简版

2015-05-06

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Headache：孕期偏头痛，警惕代谢疾病

2015-04-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JADA：健康的微笑离不开健康的牙龈

2015-04-27

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

专家解读2015ADA/EASD高血糖管理立场声明

2015-03-21

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Headache：美国头痛学会AHS 急性偏头痛的药物治疗

2015-02-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA和EASD联合发布：全新2型糖尿病管理指南

2015-02-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

免疫测序界重磅新闻：Adaptive收购Sequenta，一跃成为行业巨头

2015-01-15

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

拜耳造影剂Gadavist新适应症获FDA批准，用于两周岁以下患儿

2015-01-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

逆袭！赛诺菲多发性硬化症新药Lemtrada获FDA批准上市

2014-11-21

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：良好血糖控制有助于降低心血管事件（CREDIT研究）

2014-07-09

科室
- - 订阅+
  - 更多科室
工具
服务